Skip to main content
Top
Published in: Archives of Orthopaedic and Trauma Surgery 1/2018

01-01-2018 | Knee Arthroplasty

Does tranexamic acid increase the risk of thromboembolism after bilateral simultaneous total knee arthroplasties in Asian Population?

Authors: Young-Hoo Kim, Jang-Won Park, Jun-Shik Kim, Dong-Hyuk Seo

Published in: Archives of Orthopaedic and Trauma Surgery | Issue 1/2018

Login to get access

Abstract

Purpose

To ascertain whether tranexamic acid reduces the blood loss and transfusion rate and volumes; increase the prevalence of deep vein thrombosis (DVT); and investigate factors associated with DVT in patients undergoing primary bilateral total knee arthroplasties (TKAs) without use of chemical thromboprophylaxis.

Methods

There were 874 patients (1748 knees) in the control group who did not receive tranexamic acid and 871 patients (1742 knees) in the study group who received tranexamic acid. Mechanical compression device was applied without any chemical thromboprophylaxis. Transfusion rates and volumes were recorded. DVT was diagnosed using both sonogram and venogram at 7 or 8 day post-operatively.

Results

Intra- and post-operative blood loss and transfusion volumes were significantly lower in the tranexamic acid group. The prevalence of DVT was 14% (245 of 1748 knees) in the control group and 18% (314 of 1742 knees) in the tranexamic acid group. Pre- and post-operative perfusion lung scans revealed no evidence of PE in any patients in either group. Coagulation or thrombophilic data or molecular genetic testing was not significantly different between the two groups.

Conclusion

The use of tranexamic acid reduces the volume of blood transfusion and does not increase the prevalence of DVT or PE in the patients who did not receive routine chemical thromboprophylaxis after primary bilateral simultaneous sequential TKAs in Asian patients.
Literature
1.
go back to reference Aguilera X, Martinez-Zapata MJ, Hinarejos P, Jordán M, Leal J, González JC, Monllau JC, Celaya F, Rodriquez-Arias A, Fernández JA, Pelfort X, Puig-Verdie LI (2015) Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial. Arch Orthop Trauma Surg 135:1017CrossRefPubMed Aguilera X, Martinez-Zapata MJ, Hinarejos P, Jordán M, Leal J, González JC, Monllau JC, Celaya F, Rodriquez-Arias A, Fernández JA, Pelfort X, Puig-Verdie LI (2015) Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial. Arch Orthop Trauma Surg 135:1017CrossRefPubMed
2.
go back to reference Benoni G, Fredin H, Knebel R, Nilsson P (2001) Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand 72:442CrossRefPubMed Benoni G, Fredin H, Knebel R, Nilsson P (2001) Blood conservation with tranexamic acid in total hip arthroplasty: a randomized, double-blind study in 40 primary operations. Acta Orthop Scand 72:442CrossRefPubMed
3.
go back to reference Cid J, Lozano M (2005) Tranexamic acid reduces allogenic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion 45:1302CrossRefPubMed Cid J, Lozano M (2005) Tranexamic acid reduces allogenic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Transfusion 45:1302CrossRefPubMed
4.
go back to reference Ellis MH, Fredman B, Zohar E, Ifrach N, Jedeikin R (2003) The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Br J Anaesth 90:596CrossRef Ellis MH, Fredman B, Zohar E, Ifrach N, Jedeikin R (2003) The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Br J Anaesth 90:596CrossRef
5.
go back to reference Graham ID, Alvarez G, Tetrol J, McAuley L, Lasepacis A (2002) Factors influencing the adoption of blood alternatives to minimize allogenic transfusion: the perspective of eight Ontario hospitals. Can J Surg 45:132PubMedPubMedCentral Graham ID, Alvarez G, Tetrol J, McAuley L, Lasepacis A (2002) Factors influencing the adoption of blood alternatives to minimize allogenic transfusion: the perspective of eight Ontario hospitals. Can J Surg 45:132PubMedPubMedCentral
6.
go back to reference Ho KM, Ismail H (2003) Use of intravenous tranexamic acid to reduce allogenic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anesth Intensive care 31:529 Ho KM, Ismail H (2003) Use of intravenous tranexamic acid to reduce allogenic blood transfusion in total hip and knee arthroplasty: a meta-analysis. Anesth Intensive care 31:529
7.
go back to reference Hourlier H, Reina N, Fennema P (2015) Single dose intravenous tranexamic acid as effective as continuous infusion in primary total knee arthroplasty: a randomized clinical trial. Arch Orthop Trauma Surg 135:465–471CrossRefPubMed Hourlier H, Reina N, Fennema P (2015) Single dose intravenous tranexamic acid as effective as continuous infusion in primary total knee arthroplasty: a randomized clinical trial. Arch Orthop Trauma Surg 135:465–471CrossRefPubMed
8.
go back to reference Husted H, Blond L, Sonne-Holm S, Holm G, Jacobsen TW, Gebuhr P (2003) Tranexamic acid reduces blood loss and blood transfusion in primary total hip arthroplasty: a prospective randomized double-blind study in 40 patients. Acta Orthop Scand 74:665–669CrossRefPubMed Husted H, Blond L, Sonne-Holm S, Holm G, Jacobsen TW, Gebuhr P (2003) Tranexamic acid reduces blood loss and blood transfusion in primary total hip arthroplasty: a prospective randomized double-blind study in 40 patients. Acta Orthop Scand 74:665–669CrossRefPubMed
9.
go back to reference Hynes M, Calder P, Scott G (2003) The use of tranexamic acid to reduce the blood loss during total knee arthroplasty. Knee 10:375–377CrossRefPubMed Hynes M, Calder P, Scott G (2003) The use of tranexamic acid to reduce the blood loss during total knee arthroplasty. Knee 10:375–377CrossRefPubMed
10.
go back to reference Ido K, Neo M, Asada Y, Kondo K, Morita T, Sakamoto T, Hayashi R, Kuriyama S (2000) Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg 120:518–520CrossRefPubMed Ido K, Neo M, Asada Y, Kondo K, Morita T, Sakamoto T, Hayashi R, Kuriyama S (2000) Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg 120:518–520CrossRefPubMed
11.
go back to reference Irwin A, Khan SK, Jameson SS, Tate RC, Copeland C, Reed MR (2013) Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement. Results of 3000 procedures. Bone Joint J 95:1556–1561CrossRefPubMed Irwin A, Khan SK, Jameson SS, Tate RC, Copeland C, Reed MR (2013) Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement. Results of 3000 procedures. Bone Joint J 95:1556–1561CrossRefPubMed
12.
go back to reference Jain NP, Nisthane PP, Shah NA (2016) Combined administration of systemic and topical tranexamic acid for total knee arthroplasty: can it be a better regimen and yet safe? A randomized controlled trial. J Arthroplast 31:542–547CrossRef Jain NP, Nisthane PP, Shah NA (2016) Combined administration of systemic and topical tranexamic acid for total knee arthroplasty: can it be a better regimen and yet safe? A randomized controlled trial. J Arthroplast 31:542–547CrossRef
13.
go back to reference Johansson T, Pettersson LG, Lisander B (2005) Tranexamic acid in total hip arthroplasty saves blood and money: a randomized double-blind study in 100 patients. Acta Orthop 76:314–319PubMed Johansson T, Pettersson LG, Lisander B (2005) Tranexamic acid in total hip arthroplasty saves blood and money: a randomized double-blind study in 100 patients. Acta Orthop 76:314–319PubMed
14.
go back to reference Kagoma YK, Crowther MA, Douketis J, Bhandan M, Eihelboom J, Lim W (2009) Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 123:687–696CrossRefPubMed Kagoma YK, Crowther MA, Douketis J, Bhandan M, Eihelboom J, Lim W (2009) Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 123:687–696CrossRefPubMed
15.
go back to reference Kim Y-H, Kim J-S (2002) Incidence and natural history of deep-vein thrombosis after total knee arthroplasty. A prospective randomized study. J Bone Joint Surg Br 84:566–570CrossRefPubMed Kim Y-H, Kim J-S (2002) Incidence and natural history of deep-vein thrombosis after total knee arthroplasty. A prospective randomized study. J Bone Joint Surg Br 84:566–570CrossRefPubMed
16.
go back to reference Kim Y-H, Yoo J-H, Kim J-S (2007) Factors leading to decreased rates of deep vein thrombosis and pulmonary embolism after total knee arthroplasty. J Arthroplast 22:974–980CrossRef Kim Y-H, Yoo J-H, Kim J-S (2007) Factors leading to decreased rates of deep vein thrombosis and pulmonary embolism after total knee arthroplasty. J Arthroplast 22:974–980CrossRef
17.
go back to reference Kim Y-H (1990) Incidence of deep vein thrombosis after cementless and cemented knee replacement. J Bone Joint Surg Br 72:779–783PubMed Kim Y-H (1990) Incidence of deep vein thrombosis after cementless and cemented knee replacement. J Bone Joint Surg Br 72:779–783PubMed
18.
go back to reference Lemay E, Guay J, Côté C, Roy A (2004) Tranexamic acid reduces the need for allogenic red blood cell transfusion in patients undergoing total hip replacement. Can J Anaesth 51:31CrossRefPubMed Lemay E, Guay J, Côté C, Roy A (2004) Tranexamic acid reduces the need for allogenic red blood cell transfusion in patients undergoing total hip replacement. Can J Anaesth 51:31CrossRefPubMed
19.
go back to reference Lindoff C, Rybo G, Astedt B (1993) Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost 70:238–240PubMed Lindoff C, Rybo G, Astedt B (1993) Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost 70:238–240PubMed
20.
go back to reference Martin JG, Cassatt KB, Kincaid-Cinnamon KA, Westendorf DS, Garton AS, Lemke JH (2014) Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. J Arthroplast 29:889–894CrossRef Martin JG, Cassatt KB, Kincaid-Cinnamon KA, Westendorf DS, Garton AS, Lemke JH (2014) Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. J Arthroplast 29:889–894CrossRef
21.
go back to reference Shemshaki H, Nourian SM, Nourian SM, Nourian N, Dehghani M, Mokhtari M, Mazoochian F (2015) One step closer to sparing total blood loss and transfusion rate in total knee arthroplasty: a meta-analysis of different methods of tranexamic acid administration. Arch Orthop Trauma Surg 135:573–588CrossRefPubMed Shemshaki H, Nourian SM, Nourian SM, Nourian N, Dehghani M, Mokhtari M, Mazoochian F (2015) One step closer to sparing total blood loss and transfusion rate in total knee arthroplasty: a meta-analysis of different methods of tranexamic acid administration. Arch Orthop Trauma Surg 135:573–588CrossRefPubMed
22.
go back to reference Wong J, Abrishami A, Beheiry HEL, Mahomed NN, Davey R, Gandhi R, Syed KA, Hasan SMO, Silva YD, Chung F (2010) Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty. J Bone Joint Surg Am 92:2503–2513CrossRefPubMed Wong J, Abrishami A, Beheiry HEL, Mahomed NN, Davey R, Gandhi R, Syed KA, Hasan SMO, Silva YD, Chung F (2010) Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty. J Bone Joint Surg Am 92:2503–2513CrossRefPubMed
23.
go back to reference Xie J, Ma J, Kang P, Zhou Z, Shen B, Yang J, Pei F (2015) Does tranexamic acid alter the risk of thromboembolism following primary total knee arthroplasty with sequential earlier anticoagulation? A large, single center, prospective cohort study of consecutive cases. Thromb Res 136:234–238CrossRefPubMed Xie J, Ma J, Kang P, Zhou Z, Shen B, Yang J, Pei F (2015) Does tranexamic acid alter the risk of thromboembolism following primary total knee arthroplasty with sequential earlier anticoagulation? A large, single center, prospective cohort study of consecutive cases. Thromb Res 136:234–238CrossRefPubMed
24.
go back to reference Yang ZG, Chen WP, Wu LD (2012) Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 94:1153–1159CrossRefPubMed Yang ZG, Chen WP, Wu LD (2012) Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 94:1153–1159CrossRefPubMed
25.
go back to reference Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, Samama CM, Molliex S (2006) Do antifibrinolytics reduce allogenic blood transfusion in orthopedic surgery? Anesthesiology 105:1034–1046CrossRefPubMed Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, Samama CM, Molliex S (2006) Do antifibrinolytics reduce allogenic blood transfusion in orthopedic surgery? Anesthesiology 105:1034–1046CrossRefPubMed
Metadata
Title
Does tranexamic acid increase the risk of thromboembolism after bilateral simultaneous total knee arthroplasties in Asian Population?
Authors
Young-Hoo Kim
Jang-Won Park
Jun-Shik Kim
Dong-Hyuk Seo
Publication date
01-01-2018
Publisher
Springer Berlin Heidelberg
Published in
Archives of Orthopaedic and Trauma Surgery / Issue 1/2018
Print ISSN: 0936-8051
Electronic ISSN: 1434-3916
DOI
https://doi.org/10.1007/s00402-017-2791-y

Other articles of this Issue 1/2018

Archives of Orthopaedic and Trauma Surgery 1/2018 Go to the issue